期刊文献+

Exendin-4改善胰岛素抵抗的作用机制研究 被引量:3

The study of mechanism for exendin-4 (exenatide) improving insulin resistance
下载PDF
导出
摘要 目的探讨exendin-4(exenatide)对高脂诱导胰岛素抵抗(IR)大鼠胰岛素敏感性(IS)改善的机制及对脂肪细胞因子的影响。方法健康雄性SD大鼠随机分为正常饮食组(NC)、高脂组(HF)和高脂+Exenatide组(HE)。HE组给予exenatide(2μg/kg,日二次)腹腔注射6周,用静脉胰岛素耐量试验评价各组IS变化,观察各组肌肉和脂肪组织胰岛素信号传导、脂肪细胞因子表达和血浆浓度变化。结果6周后,HE组Lee’s指数、空腹血浆FFA、TG、TC均较NC组降低(P均<0.01),IR明显改善;胰岛素刺激后HE组肌肉和脂肪组织IRS-1酪氨酸磷酸化升高(P<0.05);HF和HE组血浆内脏脂肪素(visfatin)水平明显降低(P<0.05,P<0.01),但HE组脂联素(APN)血浆水平和脂肪组织mRNA表达明显高于HF和NC组(P均<0.01)。结论Exenatide明显改善了高脂大鼠IR,其胰岛素增敏机制可能与增强IRS-1酪氨酸磷酸化以及对APN、visfatin等脂肪细胞因子的影响有关。 Objective To investigate the effects of exendin-4 (exenatide) on insulin sensitivity and adipocytokine in high-fat-fed rats. Methods Rats were divided randomly into normal-chow group (NC), high-fat group (HF) and high-fat+exendin treated group (HE). HE rats were given exenatide (2μg/kg) twice daily for 6 wk. The insulin sensitivity was evaluated by intravenous insulin tolerance test (IVITT). Insulin-stimulated changes in insulin signal transduction, visfatin and adiponectin mRNA expressions as well as their plasma levels were also observed in these rats. Results Plasma free fatty acids (FFA), triglyceride (TG), total cholesterol (TC) levels were significantly reduced after exenatide treatment (in HE rats all P〈0.01), And IVITT parameters were also improved in these rats. Insulin-stimulated IRS-1 tyrosine phosphorylation was slightly increased in exenatide-treated rats as compared with HF rats (P〈 0.05). In addition,plasma visfatin level was significantly reduced in HF and HE groups as compared with controls (P〈0.05 and P〈0.01). The adiponectin mRNA expression in adipose tissues and circulating adiponectin level were significantly elevated in exenatide-treated rats as compared with untreated rats and controls (P 〈 0.01 ). Conclusions Chronic exenatide treatment improves insulin resistance in high-fat-fed rats , and the changes of IRS-1 tyrosine phosphorylation and adiponectin may be related to the role of exenatide in elevating insulin sensitivity.
出处 《中国糖尿病杂志》 CAS CSCD 北大核心 2008年第7期405-408,共4页 Chinese Journal of Diabetes
基金 国家自然科学基金资助项目(30270631和30370671) 国家教委春晖计划资助项目(2003-56) 美国NIH基金资助项目(R01HL073267,DK066003)
关键词 EXENDIN-4 胰岛素抵抗 脂肪细胞因子 胰岛素信号系统 Exendin-4 (Exenatide) Insulin resistance Adipocytokine Insulin signal system
  • 相关文献

参考文献8

  • 1Hansen L, Deacon CF, Orskov C, et al. Glucagon-like peptide- 1- (7-36) amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of porcine intestine. Endocrinology, 1999,140:5356-5363.
  • 2Hansotia T, Maida A, Flock G, et al. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure J Clin Invest, 2007,117:143-152.
  • 3Degn KB, Brock B, Juhl CB, et al. Effect of intravenous infusion of exenatide (synthetic exendin-4) on glucose-dependent insulin secretion and counterregulation during hypoglycemia. Diabetes, 2004, 53:2397-2403.
  • 4Gedulin BR, Nikoulina SE, Smith PA, et al. Exenatide (exendin-4) improves insulin sensitivity and { beta }-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glyeemia and body weight. Endocrinology, 2005,146 : 2069-2076.
  • 5Idris I,Pafiag D,Gray S,et al. Exendin-4 increases insulin sensitivity via a PI-3-kinase-dependent mechanism: contrasting effects of GLP-1. Biochem Pharmacol, 2002,63 : 993-996.
  • 6Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin:A protein secreted by visceral fat that mimics the effects of insuliru Science, 2005, 307 : 426-430.
  • 7Yamauchi T, Kamoni J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty -acid oxition by activating AMP-activated protein kinase. Nat Med, 2002, 8: 1288-1295.
  • 8杨媚,杨刚毅,李伶,李清明,阮华玲,阳皓,李钶,孙勤,唐毅,Gunther Boden.不同糖耐量个体血浆内脂素水平的变化[J].中华内分泌代谢杂志,2006,22(3):245-247. 被引量:76

二级参考文献7

  • 1Trayhum P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc,2001,60:329-339.
  • 2Hug C, Lodish HF. Visfatin: A new adipokine. Science, 2005,307:366-367.
  • 3Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: A protein secreted by visceral fat that mimics the effects of insulin. Science, 2005,307:426-430.
  • 4Chen MP, Chung FM, Chang DM, et al. Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab, 2006,91:295-299.
  • 5Kralisch S, Klein J, Lossner U, et al. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol, 2005,185:R1-8.
  • 6Berndt J, Kloting N, Kralisch S, et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes, 2005,54:2911-2916.
  • 7Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med, 2005,6:45-50.

共引文献75

同被引文献33

  • 1袁美玲,倪红兵.2型糖尿病载脂蛋白ApoA1、ApoB100检测的临床研究[J].南通大学学报(医学版),2009,29(6):432-433. 被引量:2
  • 2Gao H,Wang X,Zhang Z,et al.GLP-1 amplifies insulin signaling by up-regulation of IRbeta,IRS-1 and Glut4 in 3T3-L1 adipocytes.Endocrine,2007,32:90-95.
  • 3Villanueva-Peacarrillo ML,Márquez L,González N et al.Effect of GLP-1 on lipid metabolism in human adipocytes.Horm Metab Res,2001,33:73-77.
  • 4Gedulin BR,Nikoulina SE,Smith PA,et al.Exenatide (exendin-4) improves insulin sensitivity and B-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.Endocrinology,2005,146:2069-2076.
  • 5Kolterman OG,Kim DD,Shen L,et al.Pharmacokinetics,pharmacolynamics and safety of exenatide in patients with type 2 diabetes mellitus.Am J Health Pharm,2005,62:173-181.
  • 6Kershaw EE,Hamm JK,Verhagen LA,et al.Adipose triglyceride lipase:function regulation by insulin and comparison with adiponutrin.Diabetes,2006,55:148-157.
  • 7Pannacciulli N,Le DS,Salbe AD,et al.Postprandial glucagon-like peptide-1(GLP-1)response is positively associated with changes in neuronal activity of brain areas implicated in satiety and food intake regulation in humans.Neuroimage,2007,35:511-517.
  • 8Defronzo RA,Ratner RE,Han J,et al.Effects of Exenatide (Exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes.Diabetes Care,2005,28:1092-1100.
  • 9Hansotia T,Maida A,Flock G,et al.Extrapancreatic incretin receptors modulate glucose homeostasis,body weight,and energy expenditure.J Clin Invest,2007,117:143-152.
  • 10Dillon JS,Lu M,Bowen S,et al.The recombinant rat glucagon-like peptide-1 receptor expressed in an alpha-cell line,is coupled to adenylyl cyclase activation and intracellular calcium release.Exp Clin Endocrinol Diabetes,2005,113:182-189.

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部